Federal award (DEFINITIVE CONTRACT, fiscal year 2022)
Recipient: PROTEIOS TECHNOLOGY, INC.
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2023-09-15 to 2025-09-14
Current total value of award: $2049979
Description: SBIR PHASE II, TOPIC 429: A NEW PARADIGM FOR AUTOLOGOUS AND ALLOGENEIC CELL THERAPY MANUFACTURING